The Journal of Community and Supportive OncologyHallmark tumor metabolism becomes a validated therapeutic targetDecember 10, 2017Breast CancerGastroenterologyGenitourinary CancerLeukemia, Myelodysplasia, TransplantationGastrointestinal Cancer
Hematology TimesCompany launches digital PCR test for monitoring CMLDecember 7, 2017Leukemia, Myelodysplasia, TransplantationCML
Hematology TimesHealth Canada approves midostaurin for AMLDecember 6, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesCompanies launch generic busulfan in USDecember 6, 2017Leukemia, Myelodysplasia, TransplantationPharmacyCML
Hematology TimesSystem helps predict RFS, OS in BCP-ALLDecember 5, 2017Leukemia, Myelodysplasia, TransplantationPediatricsALL
Oncology PracticeASCO platelet transfusion guidelines updatedDecember 4, 2017Leukemia, Myelodysplasia, TransplantationPatient & Survivor CareTransfusion Medicine
Hematology TimesAntimalarial could aid treatment of ALLDecember 4, 2017Leukemia, Myelodysplasia, TransplantationALL
Hematology TimesDrug receives fast track designation for FLT3+ rel/ref AMLDecember 2, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
The Journal of Community and Supportive OncologyFamilial essential thrombocythemia associated with JAK2 V617F mutation in siblingsDecember 1, 2017Leukemia, Myelodysplasia, TransplantationPatient & Survivor Care
Hematology TimesStudy reveals potential target for AML treatmentNovember 30, 2017Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesFDA grants drug orphan designation for AML, MDSNovember 30, 2017AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Hospital Physician: Hematology/OncologyHairy Cell LeukemiaNovember 29, 2017Leukemia, Myelodysplasia, Transplantation
Hematology NewsResearchers identify potential gene target for AML drug developmentNovember 28, 2017AMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesStudy reveals predictor of early mortality in AMLNovember 28, 2017Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesHow CLL patients weigh treatment efficacy, safety, and costNovember 26, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
